Abacavir

ARV U.S. Brand Name
Ziagen
ARV Abbreviation(s)
ABC
First U.S. Approval
Formulations
Strength Formulation Image Description Boosted
300 mg
Film-Coated Tablets
Yellow oblong tablet with "GX 623" imprint on both sides
No
240 mL
Oral Solution
No
Generic Available?
Yes
Hide from dropdown
Off
Displaying 1 - 8 of 8
Interaction Color Code Clinical Bottom Line Clinical Effects Drug 1 effect Drug 2 dose Drug 2 effect Management
Tenofovir disoproxil fumarate ABC 740 Green: Administer standard doses Administer standard doses

No significant change

300 mg x 1

No significant change

Abacavir AZT, ZDV 671 Green: Administer standard doses Administer standard doses

Inconsistent effect across all dosing regimens; No effect on AUC with clinical abacavir dose of 300mg BID

200 mg TID, 300 mg BID

No significant change

Abacavir AZT, ZDV 670 Green: Administer standard doses Administer standard doses

No significant change

300 mg x 1 dose

Zidovudine Cmax decreased 20%; AUC no significant change

Abacavir 3TC 669 Green: Administer standard doses Administer standard doses

No significant change

150 mg x 1 dose

Lamivudine Cmax decreased 35%; AUC decreased 15%

Abacavir Ethanol 668 Green: Administer standard doses Administer standard doses

Abacavir AUC increased 41%; half-life: increased 26%; Cmax increased 15%; T1 / 2 increased

0.7 g / kg body weight

No significant change

Abacavir MMF, MPA 667 Green: Administer standard doses Administer standard doses

No significant change

500 mg BID x 16 weeks
Abacavir Methadone 666 Yellow: Adjust dosing Adjust dosing to avoid reduced levels of methadone

Potential for decreased methadone effects (e.g., withdrawal)

No significant change

40 mg once daily; 90 mg once daily

Methadone clearance increased 22%

If coadministering monitor for signs and symptoms of methadone withdrawal. Some patients may require an increased methadone dose

Abacavir